These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 33206686)
1. Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms. Grohová A; Dáňová K; Adkins I; Šumník Z; Petruželková L; Obermannová B; Koloušková S; Špíšek R; Palová-Jelínková L PLoS One; 2020; 15(11):e0242092. PubMed ID: 33206686 [TBL] [Abstract][Full Text] [Related]
2. The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis. Wang Y; Tian J; Wang S Semin Arthritis Rheum; 2016 Feb; 45(4):490-5. PubMed ID: 26272193 [TBL] [Abstract][Full Text] [Related]
3. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets. Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D Front Immunol; 2019; 10():475. PubMed ID: 30936876 [TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells. Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569 [TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy. Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998 [TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets. Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893 [No Abstract] [Full Text] [Related]
8. Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice. Wang Y; Tian J; Tang X; Rui K; Tian X; Ma J; Ma B; Xu H; Lu L; Wang S Oncotarget; 2016 Mar; 7(13):15356-68. PubMed ID: 26885611 [TBL] [Abstract][Full Text] [Related]
9. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events. Xing YF; Cai JR; Qin JJ; Zhou WY; Li CM; Li X Front Immunol; 2020; 11():577253. PubMed ID: 33584644 [TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients. Whitfield-Larry F; Felton J; Buse J; Su MA Clin Immunol; 2014 Jul; 153(1):156-64. PubMed ID: 24769355 [TBL] [Abstract][Full Text] [Related]
13. Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes. Kikodze N; Pantsulaia I; Rekhviashvili Kh; Iobadze M; Dzhakhutashvili N; Pantsulaia N; Kukuladze N; Bikashvili N; Metreveli D; Chikovani T Georgian Med News; 2013 Sep; (222):29-35. PubMed ID: 24099812 [TBL] [Abstract][Full Text] [Related]
14. Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype. Köstlin N; Vogelmann M; Spring B; Schwarz J; Feucht J; Härtel C; Orlikowsky TW; Poets CF; Gille C Immunology; 2017 Sep; 152(1):89-101. PubMed ID: 28464218 [TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells shift Th17/Treg ratio and promote systemic lupus erythematosus progression through arginase-1/miR-322-5p/TGF-β pathway. Pang B; Zhen Y; Hu C; Ma Z; Lin S; Yi H Clin Sci (Lond); 2020 Aug; 134(16):2209-2222. PubMed ID: 32808653 [TBL] [Abstract][Full Text] [Related]
16. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer. Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability. Zhao Y; Shao Q; Zhu H; Xu H; Long W; Yu B; Zhou L; Xu H; Wu Y; Su Z Cancer Sci; 2018 Sep; 109(9):2677-2686. PubMed ID: 29959821 [TBL] [Abstract][Full Text] [Related]
18. Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function. Köstlin N; Schoetensack C; Schwarz J; Spring B; Marmé A; Goelz R; Brodbeck G; Poets CF; Gille C Front Immunol; 2018; 9():1098. PubMed ID: 29868036 [TBL] [Abstract][Full Text] [Related]
19. Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery. Agrati C; Tumino N; Bordoni V; Pinnetti C; Sabatini A; Amendola A; Abbate I; Lorenzini P; Mondi A; Casetti R; Cimini E; Grassi G; Antinori A; Sacchi A Front Immunol; 2019; 10():1886. PubMed ID: 31440256 [TBL] [Abstract][Full Text] [Related]